Display options
Cite
Williamson AL. The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa. J Clin Med. 2015;4(4):579-92doi: 10.3390/jcm4040579.
Williamson, A. L. (2015). The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa. Journal of clinical medicine, 4(4), 579-92. https://doi.org/10.3390/jcm4040579
Williamson, Anna-Lise. "The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa." Journal of clinical medicine vol. 4,4 (2015): 579-92. doi: https://doi.org/10.3390/jcm4040579
Williamson AL. The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa. J Clin Med. 2015 Apr 02;4(4):579-92. doi: 10.3390/jcm4040579. PMID: 26239348; PMCID: PMC4470157.
Copy Download .nbib Format: NLM
Share it on

J Clin Med. 2015 Apr 02;4(4):579-92. doi: 10.3390/jcm4040579.

The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa.

Journal of clinical medicine

Anna-Lise Williamson

Affiliations

  1. Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Groote Schuur Hospital, Observatory, Cape Town 7925, South Africa. [email protected].

PMID: 26239348 PMCID: PMC4470157 DOI: 10.3390/jcm4040579

Abstract

Sub-Saharan Africa has the highest incidence of human papillomavirus (HPV) and cervical cancer in the world, which is further aggravated by the burden of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) disease with invasive cervical cancer being an AIDS-defining cancer. The prevalence of HPV infection and associated disease is very high in HIV-infected people and continues to be a problem even after anti-retroviral therapy. In the genital tract, the interaction between HPV and HIV is complex, with infection with multiple HPV types reported to make both women and men more susceptible to HIV infection. Besides the national programmes to vaccinate girls against HPV and screen women for cervical cancer, there should be targeted cervical cancer screening, treatment and prevention programmes introduced into HIV treatment centres. There is evidence that in high HIV prevalence areas, HIV-positive women could cause increases in the prevalence of genital HPV infection in HIV-negative men and so increase the HPV circulating in the community. Condom use and circumcision reduce the acquisition of HIV-1, and also to some extent of HPV. This review will highlight what is known about the interaction of HIV and HPV, with an emphasis on research in Africa.

Keywords: HIV-1; circumcision; human papillomavirus

References

  1. N Engl J Med. 2015 Feb 19;372(8):711-23 - PubMed
  2. J Infect Public Health. 2015 Jan-Feb;8(1):1-10 - PubMed
  3. Vaccine. 2014 Sep 29;32(43):5657-61 - PubMed
  4. Nat Med. 2007 Jul;13(7):857-61 - PubMed
  5. PLoS Med. 2013;10(9):e1001509 - PubMed
  6. Lancet. 2002 Sep 28;360(9338):971-7 - PubMed
  7. J Infect Dis. 2015 Jan 15;211(2):206-15 - PubMed
  8. Int J Cancer. 2013 Sep 1;133(5):1247-52 - PubMed
  9. Front Oncol. 2014 Mar 14;4:48 - PubMed
  10. Gynecol Oncol. 2014 Sep;134(3):534-9 - PubMed
  11. Science. 2010 Sep 3;329(5996):1168-74 - PubMed
  12. Vaccine. 2013 Nov 19;31(48):5745-53 - PubMed
  13. Vaccine. 2013 Dec 29;31 Suppl 5:F32-46 - PubMed
  14. Int J Gynecol Cancer. 2013 May;23(4):716-23 - PubMed
  15. Antivir Ther. 2011;16(8):1219-26 - PubMed
  16. AIDS. 2014 Mar 13;28(5):745-52 - PubMed
  17. J Infect Dis. 2015 Mar 1;211(5):811-20 - PubMed
  18. Sex Transm Infect. 2013 Aug;89(5):350-6 - PubMed
  19. Int J Gynaecol Obstet. 2013 Dec;123(3):231-5 - PubMed
  20. Cancer Immunol Immunother. 2012 Jan;61(1):63-70 - PubMed
  21. BMC Infect Dis. 2014 Jan 31;14:51 - PubMed
  22. J Natl Cancer Inst. 2012 Nov 21;104(22):1712-23 - PubMed
  23. J Infect Dis. 2011 Feb 15;203(4):479-86 - PubMed
  24. Clin Infect Dis. 2014 Jul 1;59(1):127-35 - PubMed
  25. Virology. 2009 Feb 20;384(2):260-5 - PubMed
  26. PLoS One. 2013;8(1):e53494 - PubMed
  27. Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):153-7 - PubMed
  28. Virology. 1991 Sep;184(1):9-13 - PubMed
  29. MMWR Morb Mortal Wkly Rep. 2013 Nov 29;62(47):953-7 - PubMed
  30. BMC Cancer. 2006 May 23;6:135 - PubMed
  31. Sao Paulo Med J. 2013;131(6):405-10 - PubMed
  32. Sex Transm Infect. 2015 May;91(3):214-9 - PubMed
  33. J Med Virol. 2009 Feb;81(2):203-10 - PubMed
  34. AIDS. 2012 Nov 13;26(17):2211-22 - PubMed
  35. J Cell Mol Med. 2012 Dec;16(12):3096-104 - PubMed
  36. Int J Cancer. 2014 Mar 15;134(6):1389-98 - PubMed
  37. AIDS Patient Care STDS. 2015 Jan;29(1):4-12 - PubMed
  38. Virus Res. 2006 Nov;121(2):220-2 - PubMed
  39. Curr Opin Virol. 2013 Aug;3(4):416-21 - PubMed
  40. J Infect Dis. 2012 Jul 1;206(1):15-27 - PubMed
  41. AIDS. 2010 Oct 23;24(16):2553-61 - PubMed
  42. Int J Cancer. 2013 Sep 15;133(6):1271-85 - PubMed
  43. Int J Gynecol Cancer. 2001 May-Jun;11(3):194-7 - PubMed
  44. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003362 - PubMed
  45. J Virol. 2014 Jan;88(1):710-6 - PubMed
  46. AIDS. 2010 Oct;24 Suppl 4:S40-9 - PubMed
  47. Trop Med Int Health. 2014 Sep;19(9):1015-28 - PubMed
  48. J Infect Dis. 2013 Jun 1;207(11):1713-22 - PubMed
  49. Clin Infect Dis. 2015 May 15;60(10):1559-68 - PubMed
  50. PLoS One. 2014 Apr 16;9(4):e94547 - PubMed
  51. Diagn Cytopathol. 2011 Jan;39(1):65-72 - PubMed
  52. Sex Transm Infect. 2014 Sep;90(6):455-62 - PubMed
  53. J Infect Dis. 2011 Apr 15;203(8):1182-91 - PubMed
  54. J Infect Dis. 2015 Feb 1;211(3):405-15 - PubMed
  55. Vaccine. 2012 Nov 20;30 Suppl 5:F168-74 - PubMed
  56. Infect Dis Obstet Gynecol. 2011;2011:692012 - PubMed
  57. Sci Rep. 2014 Mar 18;4:4398 - PubMed
  58. J Infect Dis. 1995 Jul;172(1):235-8 - PubMed
  59. Discov Med. 2012 Aug;14(75):125-31 - PubMed
  60. Int J Cancer. 2012 Nov 15;131(10):2349-59 - PubMed
  61. Int J Cancer. 2015 Jan 1;136(1):98-107 - PubMed
  62. Lancet Infect Dis. 2007 Jul;7(7):453-9 - PubMed
  63. AIDS. 2010 Apr 24;24(7):1035-42 - PubMed
  64. Vaccine. 2013 Dec 29;31 Suppl 5:F60-72 - PubMed
  65. Br J Cancer. 2014 Oct 28;111(9):1824-30 - PubMed
  66. Infect Agent Cancer. 2014 Feb 26;9(1):7 - PubMed
  67. BMC Infect Dis. 2010 Oct 14;10:295 - PubMed
  68. AIDS. 2015 Jan 2;29(1):59-66 - PubMed
  69. Am J Clin Pathol. 1994 Dec;102(6):768-74 - PubMed
  70. BMC Cancer. 2009 Aug 07;9:275 - PubMed
  71. Fam Plann Perspect. 1999 Nov-Dec;31(6):272-9 - PubMed
  72. Cancer Chemother Pharmacol. 2014 Nov;74(5):1033-8 - PubMed
  73. J Infect Dis. 2013 Aug 1;208(3):373-84 - PubMed
  74. Acta Cytol. 2009 Jan-Feb;53(1):10-7 - PubMed
  75. Recent Results Cancer Res. 2014;193:11-32 - PubMed
  76. J Gen Virol. 2010 Dec;91(Pt 12):3023-31 - PubMed
  77. Int J STD AIDS. 2014 Mar;25(3):163-77 - PubMed

Publication Types